Stanley Fahn, David Oakes, Ira Shoulson et Karl Kieburtz, « Levodopa and the progression of Parkinson's disease », The New England Journal of Medicine, vol. 351, no 24, , p. 2498–2508 (ISSN1533-4406, PMID15590952, DOI10.1056/NEJMoa033447, lire en ligne, consulté le )
PD Med Collaborative Group, Richard Gray, Natalie Ives et Caroline Rick, « Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial », Lancet (London, England), vol. 384, no 9949, , p. 1196–1205 (ISSN1474-547X, PMID24928805, DOI10.1016/S0140-6736(14)60683-8, lire en ligne, consulté le )
(en) Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, Ibrahim NM, « Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease », PLoS One, vol. 9, no 11, , e112330. (PMID25411976, PMCIDPMC4239049, DOI10.1371/journal.pone.0112330, lire en ligne [html])modifier
Daniel Weintraub, Juergen Koester, Marc N. Potenza et Andrew D. Siderowf, « Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients », Archives of Neurology, vol. 67, no 5, , p. 589–595 (ISSN1538-3687, PMID20457959, DOI10.1001/archneurol.2010.65, lire en ligne, consulté le )
M. Dostal, C. Weber-Schoendorfer, J. Sobesky et C. Schaefer, « Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series », European Journal of Neurology, vol. 20, no 9, , p. 1241–1246 (ISSN1468-1331, PMID23083216, DOI10.1111/ene.12001, lire en ligne, consulté le )
M. Pierantozzi, A. Pietroiusti, L. Brusa et S. Galati, « Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations », Neurology, vol. 66, no 12, , p. 1824–1829 (ISSN0028-3878 et 1526-632X, DOI10.1212/01.wnl.0000221672.01272.ba, lire en ligne, consulté le )
Vayu Maini Rekdal, Elizabeth N. Bess, Jordan E. Bisanz et Peter J. Turnbaugh, « Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism », Science, vol. 364, no 6445, , eaau6323 (ISSN0036-8075 et 1095-9203, DOI10.1126/science.aau6323, lire en ligne, consulté le )
issn.org
portal.issn.org
Stanley Fahn, David Oakes, Ira Shoulson et Karl Kieburtz, « Levodopa and the progression of Parkinson's disease », The New England Journal of Medicine, vol. 351, no 24, , p. 2498–2508 (ISSN1533-4406, PMID15590952, DOI10.1056/NEJMoa033447, lire en ligne, consulté le )
PD Med Collaborative Group, Richard Gray, Natalie Ives et Caroline Rick, « Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial », Lancet (London, England), vol. 384, no 9949, , p. 1196–1205 (ISSN1474-547X, PMID24928805, DOI10.1016/S0140-6736(14)60683-8, lire en ligne, consulté le )
Daniel Weintraub, Juergen Koester, Marc N. Potenza et Andrew D. Siderowf, « Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients », Archives of Neurology, vol. 67, no 5, , p. 589–595 (ISSN1538-3687, PMID20457959, DOI10.1001/archneurol.2010.65, lire en ligne, consulté le )
M. Dostal, C. Weber-Schoendorfer, J. Sobesky et C. Schaefer, « Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series », European Journal of Neurology, vol. 20, no 9, , p. 1241–1246 (ISSN1468-1331, PMID23083216, DOI10.1111/ene.12001, lire en ligne, consulté le )
B. R. Goldin, M. A. Peppercorn et P. Goldman, « Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat », The Journal of Pharmacology and Experimental Therapeutics, vol. 186, no 1, , p. 160–166 (ISSN0022-3565, PMID4723308, lire en ligne, consulté le )
M. Pierantozzi, A. Pietroiusti, L. Brusa et S. Galati, « Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations », Neurology, vol. 66, no 12, , p. 1824–1829 (ISSN0028-3878 et 1526-632X, DOI10.1212/01.wnl.0000221672.01272.ba, lire en ligne, consulté le )
Vayu Maini Rekdal, Elizabeth N. Bess, Jordan E. Bisanz et Peter J. Turnbaugh, « Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism », Science, vol. 364, no 6445, , eaau6323 (ISSN0036-8075 et 1095-9203, DOI10.1126/science.aau6323, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
Stanley Fahn, David Oakes, Ira Shoulson et Karl Kieburtz, « Levodopa and the progression of Parkinson's disease », The New England Journal of Medicine, vol. 351, no 24, , p. 2498–2508 (ISSN1533-4406, PMID15590952, DOI10.1056/NEJMoa033447, lire en ligne, consulté le )
PD Med Collaborative Group, Richard Gray, Natalie Ives et Caroline Rick, « Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial », Lancet (London, England), vol. 384, no 9949, , p. 1196–1205 (ISSN1474-547X, PMID24928805, DOI10.1016/S0140-6736(14)60683-8, lire en ligne, consulté le )
(en) Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, Ibrahim NM, « Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease », PLoS One, vol. 9, no 11, , e112330. (PMID25411976, PMCIDPMC4239049, DOI10.1371/journal.pone.0112330, lire en ligne [html])modifier
Daniel Weintraub, Juergen Koester, Marc N. Potenza et Andrew D. Siderowf, « Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients », Archives of Neurology, vol. 67, no 5, , p. 589–595 (ISSN1538-3687, PMID20457959, DOI10.1001/archneurol.2010.65, lire en ligne, consulté le )
M. Dostal, C. Weber-Schoendorfer, J. Sobesky et C. Schaefer, « Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series », European Journal of Neurology, vol. 20, no 9, , p. 1241–1246 (ISSN1468-1331, PMID23083216, DOI10.1111/ene.12001, lire en ligne, consulté le )
B. R. Goldin, M. A. Peppercorn et P. Goldman, « Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat », The Journal of Pharmacology and Experimental Therapeutics, vol. 186, no 1, , p. 160–166 (ISSN0022-3565, PMID4723308, lire en ligne, consulté le )
plos.org
journals.plos.org
(en) Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, Ibrahim NM, « Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease », PLoS One, vol. 9, no 11, , e112330. (PMID25411976, PMCIDPMC4239049, DOI10.1371/journal.pone.0112330, lire en ligne [html])modifier
(en) Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, Ibrahim NM, « Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease », PLoS One, vol. 9, no 11, , e112330. (PMID25411976, PMCIDPMC4239049, DOI10.1371/journal.pone.0112330, lire en ligne [html])modifier